MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 577451 | Name: Mirtazapine hydrobromide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Mirtazapine hydrobromide is an atypical antidepressant with noradrenergic and specific serotonergic activity.

Chemical Structure

Mirtazapine hydrobromide
Mirtazapine hydrobromide
CAS#868363-97-7 (HBr)

Theoretical Analysis

MedKoo Cat#: 577451

Name: Mirtazapine hydrobromide

CAS#: 868363-97-7 (HBr)

Chemical Formula: C17H20BrN3

Exact Mass: 345.0841

Molecular Weight: 346.27

Elemental Analysis: C, 58.97; H, 5.82; Br, 23.08; N, 12.14

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
85650-52-8 (free base) 61337-67-5 (deleted) 1448014-35-4 (HCl) 868528-74-9 (HBr) 207516-99-2 (2HCl) 341512-89-8 (hemihydrate) 868363-97-7 (HBr) 207516-99-2 (HCl) 1216678-68-0 (deuterated forms d3)
Synonym
Mirtazapine hydrobromide; Mirtazapine HBr
IUPAC/Chemical Name
Pyrazino(2,1-a)pyrido(2,3-C)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, hydrobromide (1:1)
InChi Key
JERFRCPECXNTRC-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H19N3.BrH/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;/h2-8,16H,9-12H2,1H3;1H
SMILES Code
Br.CN1CCN2C(C1)c3ccccc3Cc4cccnc24
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 346.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Praharaj SK, Kongasseri S, Behere RV, Sharma PS. Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials. Ther Adv Psychopharmacol. 2015 Oct;5(5):307-13. doi: 10.1177/2045125315601343. Review. PubMed PMID: 26557987; PubMed Central PMCID: PMC4622124. 2: Verster JC, van de Loo AJ, Roth T. Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability. Eur J Pharmacol. 2015 Apr 15;753:252-6. doi: 10.1016/j.ejphar.2014.10.032. Epub 2014 Nov 13. Review. PubMed PMID: 25446559. 3: Holland J, Bhogle M. Sertraline and mirtazapine as geriatric antidepressants. Psychiatr Danub. 2013 Sep;25 Suppl 2:S286-90. Review. PubMed PMID: 23995195. 4: Graves SM, Rafeyan R, Watts J, Napier TC. Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside. Pharmacol Ther. 2012 Dec;136(3):343-53. doi: 10.1016/j.pharmthera.2012.08.013. Epub 2012 Aug 29. Review. PubMed PMID: 22960395; PubMed Central PMCID: PMC3483434. 5: Dolder CR, Nelson MH, Iler CA. The effects of mirtazapine on sleep in patients with major depressive disorder. Ann Clin Psychiatry. 2012 Aug;24(3):215-24. Review. PubMed PMID: 22860241. 6: Lasso M, Cerón I. [Mirtazapine and antiretroviral therapy in the treatment of progressive multifocal leukoencephalopathy associated with HIV-1 infection: report of a case and review of literature]. Rev Chilena Infectol. 2012 Apr;29(2):217-20. doi: 10.4067/S0716-10182012000200016. Review. Spanish. PubMed PMID: 22689039. 7: Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2. Review. PubMed PMID: 22161405; PubMed Central PMCID: PMC4158430. 8: Phan SV, Kreys TJ. Adjunct mirtazapine for negative symptoms of schizophrenia. Pharmacotherapy. 2011 Oct;31(10):1017-30. doi: 10.1592/phco.31.10.1017. Review. PubMed PMID: 21950644. 9: Wichniak A, Wierzbicka A. [The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine]. Pol Merkur Lekarski. 2011 Jul;31(181):65-70. Review. Polish. PubMed PMID: 21870714. 10: Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review. PubMed PMID: 21764118. 11: Benjamin S, Doraiswamy PM. Review of the use of mirtazapine in the treatment of depression. Expert Opin Pharmacother. 2011 Jul;12(10):1623-32. doi: 10.1517/14656566.2011.585459. Epub 2011 Jun 6. Review. PubMed PMID: 21644844. 12: Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ECT. 2011 Jun;27(2):165-7. doi: 10.1097/YCT.0b013e3181e63346. Review. PubMed PMID: 21602639. 13: Spiegel DR, Kolb R. Treatment of irritable bowel syndrome with comorbid anxiety symptoms with mirtazapine. Clin Neuropharmacol. 2011 Jan-Feb;34(1):36-8. doi: 10.1097/WNF.0b013e318209cef2. Review. PubMed PMID: 21242743. 14: Álvarez E, Viñas F. Mirtazapine in combination. Actas Esp Psiquiatr. 2010 Mar-Apr;38(2):121-8. Review. PubMed PMID: 21361055. 15: Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. Review. PubMed PMID: 20030418. 16: Fox CB, Treadway AK, Blaszczyk AT, Sleeper RB. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly. Pharmacotherapy. 2009 Apr;29(4):383-97. doi: 10.1592/phco.29.4.383. Review. PubMed PMID: 19323618. 17: Rihmer Z, Purebl G. [Mirtazapine--pharmacologic action and clinical advantages]. Neuropsychopharmacol Hung. 2009 Mar;11(1):35-40. Review. Hungarian. PubMed PMID: 19731817. 18: Croom KF, Perry CM, Plosker GL. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006. Review. PubMed PMID: 19453203. 19: Howland RH. Understanding the clinical profile of a drug on the basis of its pharmacology: mirtazapine as an example. J Psychosoc Nurs Ment Health Serv. 2008 Dec;46(12):19-23. Review. PubMed PMID: 19133491. 20: Gillman PK. A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Hum Psychopharmacol. 2006 Mar;21(2):117-25. Review. PubMed PMID: 16342227.